Evaluation of FAK and Src expression in human benign and malignant thyroid lesions.
Focal Adhesion Kinase (FAK) and Src have been reported to regulate tumor growth, invasion, metastasis and angiogenesis. The present study aimed to evaluate by immunohistochemistry the clinical significance of FAK and Src expression in 108 patients with benign and malignant thyroid lesions. Total FAK expression provided a distinct discrimination between malignant and benign (p = 0.00001), as well as between papillary carcinoma and hyperplastic nodules thyroid lesions (p = 0.00005), being also associated with follicular cells' proliferative capacity (p = 0.0003). In malignant thyroid lesions, total FAK expression was associated with tumor size (p = 0.0455), and presence of capsular (p = 0.0102) and lymphatic (p = 0.0173) invasion. Total Src expression was borderline increased in cases of papillary carcinoma compared to hyperplastic nodules (p = 0.0993), being also correlated with tumor size (p = 0.0169). FAK and Src expression was ascribed to a significant extent to the phosphorylated forms of the enzymes, which provided a better discrimination between malignant and benign thyroid lesions. The current data revealed that FAK and to a lesser extent Src expression could be considered of clinical utility in thyroid neoplasia with potential use as therapeutic targets.
Michailidi
Christina
C
Department of Forensic Medicine and Toxicology, Medical School, University of Athens, 75 M Asias str, Goudi, GR11527 Athens, Greece.
Giaginis
Costas
C
Stolakis
Vassilios
V
Alexandrou
Paraskevi
P
Klijanienko
Jerzy
J
Delladetsima
Ioanna
I
Chatzizacharias
Nicolaos
N
Tsourouflis
Gerasimos
G
Theocharis
Stamatios
S
D000328:Adult; D000368:Aged; D002291:Carcinoma, Papillary / Q000201:enzymology; D003937:Diagnosis, Differential; D005260:Female; D051417:Focal Adhesion Kinase 1 / Q000096:biosynthesis*; D006801:Humans; D006965:Hyperplasia / Q000201:enzymology; D007150:Immunohistochemistry; D008297:Male; D008875:Middle Aged; D016392:Proto-Oncogene Proteins pp60(c-src) / Q000096:biosynthesis*; D018709:Statistics, Nonparametric; D013959:Thyroid Diseases / Q000201:enzymology; D013964:Thyroid Neoplasms / Q000201:enzymology*; D055815:Young Adult
D051417:Focal Adhesion Kinase 1; C496050:PTK2 protein, human; D016392:Proto-Oncogene Proteins pp60(c-src)
J Cell Sci. 1996 Jul;109 ( Pt 7):1787-94
8832401
Nature. 1995 Oct 12;377(6549):539-44
7566154
Cancer Res. 2003 Aug 15;63(16):5028-33
12941830
Eur J Endocrinol. 2008 Nov;159(5):493-505
18728120
Oncology. 2006;71(5-6):417-22
17687194
Expert Opin Ther Targets. 2007 Oct;11(10):1315-28
17907961
J Hepatol. 2004 Jul;41(1):104-11
15246215
Front Biosci. 1999 Jan 15;4:D102-13
9889179
Int J Cancer. 2006 Dec 15;119(12):2724-32
16998832
J Cell Sci. 2000 Dec;113 Pt 23:4221-30
11069767
Anticancer Agents Med Chem. 2007 Nov;7(6):681-4
18045062
Ann Surg Oncol. 1996 Jan;3(1):100-5
8770310
Biochimie. 2007 May;89(5):613-24
17397984
Br J Cancer. 2003 Jul 7;89(1):140-5
12838315
J Cell Biochem. 2006 Sep 1;99(1):35-52
16823799
Histol Histopathol. 2008 May;23(5):629-50
18283648
Am J Pathol. 2004 Oct;165(4):1087-95
15466376
World J Surg. 2006 Feb;30(2):219-26
16425085
Mol Biol Cell. 1994 Apr;5(4):413-21
8054685
Surgery. 2003 Aug;134(2):221-6
12947321
APMIS. 2010 Mar;118(3):210-21
20132187
J Pathol. 1996 Dec;180(4):383-8
9014858
Prog Biophys Mol Biol. 1999;71(3-4):435-78
10354709
J Hepatol. 2001 Jul;35(1):68-73
11495044
Mini Rev Med Chem. 2008 Sep;8(10):1053-63
18782057
Toxicology. 2008 Mar 12;245(1-2):1-10
18215454
Pediatr Endocrinol Rev. 2007 Jun;4(4):317-28
17643079
Lung Cancer. 2006 Sep;53(3):263-71
16842883
Biochem Biophys Res Commun. 1998 Feb 13;243(2):503-8
9480838
Breast Cancer Res Treat. 2002 Dec;76(3):261-7
12462387
Mod Pathol. 2005 Oct;18(10):1289-94
15861214
Ann Oncol. 2008 Aug;19(8):1379-1386
18487549
J Clin Invest. 1993 Jan;91(1):53-60
7678609
Oncogene. 2002 Apr 11;21(16):2513-24
11971186
Clin Cancer Res. 2004 Apr 1;10(7):2307-18
15073106
Pathol Oncol Res. 2008 Dec;14(4):457-60
18415710
Expert Opin Investig Drugs. 2003 Jan;12(1):51-64
12517254
Pathol Oncol Res. 2009 Jun;15(2):173-81
18987997
J Korean Med Sci. 2004 Oct;19(5):710-5
15483349
J Biol Chem. 1997 Nov 28;272(48):30455-62
9374537
Dig Dis Sci. 2008 Jun;53(6):1728-34
17932753
J Biol Chem. 1992 Sep 25;267(27):19031-4
1382065
Pathol Oncol Res. 2009 Dec;15(4):645-50
19381877
Cancer Metastasis Rev. 2003 Dec;22(4):359-74
12884911
Int J Biochem Cell Biol. 1997 Jul;29(7):929-34
9375372
J Biol Chem. 1998 Dec 11;273(50):33714-21
9837958
J Cell Biol. 1992 Nov;119(4):905-12
1385445
Endocrinol Metab Clin North Am. 2007 Sep;36(3):707-35, vi
17673125